img

Global COPD Therapeutics Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global COPD Therapeutics Market Research Report 2024

Chronic Obstructive Pulmonary Disease (COPD) is a progressive disorder associated with chronic inflammation of the airways and lungs. Persistent breathing difficulties and repeated exacerbations of COPD symptoms make the disease one of the leading causes of morbidity, and the fifth-leading cause of death in the world.
According to Mr Accuracy reports new survey, global COPD Therapeutics market is projected to reach US$ 849.7 million in 2029, increasing from US$ 525 million in 2022, with the CAGR of 6.0% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole COPD Therapeutics market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global COPD Therapeutics market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


GlaxoSmithKline
AstraZeneca
Theravance Biopharma
Mylan
Segment by Type
Bronchodilators
Inhaled Corticosteroids
Other

Segment by Application


Adult
Child
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The COPD Therapeutics report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global COPD Therapeutics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Bronchodilators
1.2.3 Inhaled Corticosteroids
1.2.4 Other
1.3 Market by Application
1.3.1 Global COPD Therapeutics Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Adult
1.3.3 Child
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global COPD Therapeutics Market Perspective (2018-2029)
2.2 COPD Therapeutics Growth Trends by Region
2.2.1 Global COPD Therapeutics Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 COPD Therapeutics Historic Market Size by Region (2018-2024)
2.2.3 COPD Therapeutics Forecasted Market Size by Region (2024-2029)
2.3 COPD Therapeutics Market Dynamics
2.3.1 COPD Therapeutics Industry Trends
2.3.2 COPD Therapeutics Market Drivers
2.3.3 COPD Therapeutics Market Challenges
2.3.4 COPD Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top COPD Therapeutics Players by Revenue
3.1.1 Global Top COPD Therapeutics Players by Revenue (2018-2024)
3.1.2 Global COPD Therapeutics Revenue Market Share by Players (2018-2024)
3.2 Global COPD Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by COPD Therapeutics Revenue
3.4 Global COPD Therapeutics Market Concentration Ratio
3.4.1 Global COPD Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by COPD Therapeutics Revenue in 2022
3.5 COPD Therapeutics Key Players Head office and Area Served
3.6 Key Players COPD Therapeutics Product Solution and Service
3.7 Date of Enter into COPD Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 COPD Therapeutics Breakdown Data by Type
4.1 Global COPD Therapeutics Historic Market Size by Type (2018-2024)
4.2 Global COPD Therapeutics Forecasted Market Size by Type (2024-2029)
5 COPD Therapeutics Breakdown Data by Application
5.1 Global COPD Therapeutics Historic Market Size by Application (2018-2024)
5.2 Global COPD Therapeutics Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America COPD Therapeutics Market Size (2018-2029)
6.2 North America COPD Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America COPD Therapeutics Market Size by Country (2018-2024)
6.4 North America COPD Therapeutics Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe COPD Therapeutics Market Size (2018-2029)
7.2 Europe COPD Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe COPD Therapeutics Market Size by Country (2018-2024)
7.4 Europe COPD Therapeutics Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific COPD Therapeutics Market Size (2018-2029)
8.2 Asia-Pacific COPD Therapeutics Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific COPD Therapeutics Market Size by Region (2018-2024)
8.4 Asia-Pacific COPD Therapeutics Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America COPD Therapeutics Market Size (2018-2029)
9.2 Latin America COPD Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America COPD Therapeutics Market Size by Country (2018-2024)
9.4 Latin America COPD Therapeutics Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa COPD Therapeutics Market Size (2018-2029)
10.2 Middle East & Africa COPD Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa COPD Therapeutics Market Size by Country (2018-2024)
10.4 Middle East & Africa COPD Therapeutics Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Detail
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline COPD Therapeutics Introduction
11.1.4 GlaxoSmithKline Revenue in COPD Therapeutics Business (2018-2024)
11.1.5 GlaxoSmithKline Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Detail
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca COPD Therapeutics Introduction
11.2.4 AstraZeneca Revenue in COPD Therapeutics Business (2018-2024)
11.2.5 AstraZeneca Recent Development
11.3 Theravance Biopharma
11.3.1 Theravance Biopharma Company Detail
11.3.2 Theravance Biopharma Business Overview
11.3.3 Theravance Biopharma COPD Therapeutics Introduction
11.3.4 Theravance Biopharma Revenue in COPD Therapeutics Business (2018-2024)
11.3.5 Theravance Biopharma Recent Development
11.4 Mylan
11.4.1 Mylan Company Detail
11.4.2 Mylan Business Overview
11.4.3 Mylan COPD Therapeutics Introduction
11.4.4 Mylan Revenue in COPD Therapeutics Business (2018-2024)
11.4.5 Mylan Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global COPD Therapeutics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Bronchodilators
Table 3. Key Players of Inhaled Corticosteroids
Table 4. Key Players of Other
Table 5. Global COPD Therapeutics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global COPD Therapeutics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global COPD Therapeutics Market Size by Region (2018-2024) & (US$ Million)
Table 8. Global COPD Therapeutics Market Share by Region (2018-2024)
Table 9. Global COPD Therapeutics Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global COPD Therapeutics Market Share by Region (2024-2029)
Table 11. COPD Therapeutics Market Trends
Table 12. COPD Therapeutics Market Drivers
Table 13. COPD Therapeutics Market Challenges
Table 14. COPD Therapeutics Market Restraints
Table 15. Global COPD Therapeutics Revenue by Players (2018-2024) & (US$ Million)
Table 16. Global COPD Therapeutics Market Share by Players (2018-2024)
Table 17. Global Top COPD Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in COPD Therapeutics as of 2022)
Table 18. Ranking of Global Top COPD Therapeutics Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by COPD Therapeutics Revenue (CR5 and HHI) & (2018-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players COPD Therapeutics Product Solution and Service
Table 22. Date of Enter into COPD Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global COPD Therapeutics Market Size by Type (2018-2024) & (US$ Million)
Table 25. Global COPD Therapeutics Revenue Market Share by Type (2018-2024)
Table 26. Global COPD Therapeutics Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global COPD Therapeutics Revenue Market Share by Type (2024-2029)
Table 28. Global COPD Therapeutics Market Size by Application (2018-2024) & (US$ Million)
Table 29. Global COPD Therapeutics Revenue Market Share by Application (2018-2024)
Table 30. Global COPD Therapeutics Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global COPD Therapeutics Revenue Market Share by Application (2024-2029)
Table 32. North America COPD Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America COPD Therapeutics Market Size by Country (2018-2024) & (US$ Million)
Table 34. North America COPD Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe COPD Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe COPD Therapeutics Market Size by Country (2018-2024) & (US$ Million)
Table 37. Europe COPD Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific COPD Therapeutics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific COPD Therapeutics Market Size by Region (2018-2024) & (US$ Million)
Table 40. Asia-Pacific COPD Therapeutics Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America COPD Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America COPD Therapeutics Market Size by Country (2018-2024) & (US$ Million)
Table 43. Latin America COPD Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa COPD Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa COPD Therapeutics Market Size by Country (2018-2024) & (US$ Million)
Table 46. Middle East & Africa COPD Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 47. GlaxoSmithKline Company Detail
Table 48. GlaxoSmithKline Business Overview
Table 49. GlaxoSmithKline COPD Therapeutics Product
Table 50. GlaxoSmithKline Revenue in COPD Therapeutics Business (2018-2024) & (US$ Million)
Table 51. GlaxoSmithKline Recent Development
Table 52. AstraZeneca Company Detail
Table 53. AstraZeneca Business Overview
Table 54. AstraZeneca COPD Therapeutics Product
Table 55. AstraZeneca Revenue in COPD Therapeutics Business (2018-2024) & (US$ Million)
Table 56. AstraZeneca Recent Development
Table 57. Theravance Biopharma Company Detail
Table 58. Theravance Biopharma Business Overview
Table 59. Theravance Biopharma COPD Therapeutics Product
Table 60. Theravance Biopharma Revenue in COPD Therapeutics Business (2018-2024) & (US$ Million)
Table 61. Theravance Biopharma Recent Development
Table 62. Mylan Company Detail
Table 63. Mylan Business Overview
Table 64. Mylan COPD Therapeutics Product
Table 65. Mylan Revenue in COPD Therapeutics Business (2018-2024) & (US$ Million)
Table 66. Mylan Recent Development
Table 67. Research Programs/Design for This Report
Table 68. Key Data Information from Secondary Sources
Table 69. Key Data Information from Primary Sources
List of Figures
Figure 1. Global COPD Therapeutics Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global COPD Therapeutics Market Share by Type: 2022 VS 2029
Figure 3. Bronchodilators Features
Figure 4. Inhaled Corticosteroids Features
Figure 5. Other Features
Figure 6. Global COPD Therapeutics Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global COPD Therapeutics Market Share by Application: 2022 VS 2029
Figure 8. Adult Case Studies
Figure 9. Child Case Studies
Figure 10. COPD Therapeutics Report Years Considered
Figure 11. Global COPD Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global COPD Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global COPD Therapeutics Market Share by Region: 2022 VS 2029
Figure 14. Global COPD Therapeutics Market Share by Players in 2022
Figure 15. Global Top COPD Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in COPD Therapeutics as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by COPD Therapeutics Revenue in 2022
Figure 17. North America COPD Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America COPD Therapeutics Market Share by Country (2018-2029)
Figure 19. United States COPD Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada COPD Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe COPD Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe COPD Therapeutics Market Share by Country (2018-2029)
Figure 23. Germany COPD Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France COPD Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. COPD Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy COPD Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia COPD Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries COPD Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific COPD Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific COPD Therapeutics Market Share by Region (2018-2029)
Figure 31. China COPD Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan COPD Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea COPD Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia COPD Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India COPD Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia COPD Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America COPD Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America COPD Therapeutics Market Share by Country (2018-2029)
Figure 39. Mexico COPD Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil COPD Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa COPD Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa COPD Therapeutics Market Share by Country (2018-2029)
Figure 43. Turkey COPD Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia COPD Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. GlaxoSmithKline Revenue Growth Rate in COPD Therapeutics Business (2018-2024)
Figure 46. AstraZeneca Revenue Growth Rate in COPD Therapeutics Business (2018-2024)
Figure 47. Theravance Biopharma Revenue Growth Rate in COPD Therapeutics Business (2018-2024)
Figure 48. Mylan Revenue Growth Rate in COPD Therapeutics Business (2018-2024)
Figure 49. Bottom-up and Top-down Approaches for This Report
Figure 50. Data Triangulation
Figure 51. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries